Platform Technology Partners’s Corbus Pharmaceuticals CRBP Stock Holding History

Platform Technology Partners’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,125	Closed	-$9K	–	199
2022 Q2	$9K	Hold	1,125	–	–	﹤0.01%	200
2022 Q1	$18K	Sell	1,125 -375	-25%	-$4.97K	0.01%	213
2021 Q4	$28K	Sell	1,500 -500	-25%	-$13.5K	0.01%	220
2021 Q3	$61K	Hold	2,000	–	–	0.03%	221
2021 Q2	$110K	Buy	+2,000	New	+$111K	0.05%	238
2020 Q4	$75K	Hold	2,000	–	–	0.04%	220
2020 Q3	$108K	Buy	2,000 +1,333	+200%	+$241K	0.07%	187
2020 Q2	$168K	Hold	667	–	–	0.12%	169
2020 Q1	$105K	Buy	+667	New	+$113K	0.1%	157

Other funds holding CRBP

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Platform Technology Partners's CRBP Position: Q3 2022 in Review

Platform Technology Partners sold out of Corbus Pharmaceuticals (CRBP) in Q3 2022, closing a stake of 1,125 shares — an estimated $9K sold.

Platform Technology Partners first reported a position in CRBP in Q1 2020 and held it in 9 quarters. The position peaked at $168K in Q2 2020. 64 funds tracked by Wall St. Rank hold CRBP as of Q3 2022.

Platform Technology Partners reported no remaining Corbus Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Platform Technology Partners sold 1,125 Corbus Pharmaceuticals shares in Q3 2022, an estimated $9K.
Platform Technology Partners first reported a position in Corbus Pharmaceuticals in Q1 2020 and held it in 9 quarters.
Platform Technology Partners's Corbus Pharmaceuticals position peaked at $168K in Q2 2020.
64 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2022.

Based on Platform Technology Partners's 13F filing for Q3 2022, filed 24 Oct 2022.